Advertisement

Topics

Raptor Pharmaceuticals Corp. Company Profile

20:28 EDT 25th September 2017 | BioPortfolio

Raptor Pharmaceutical Corp. ("the Company") is dedicated to speeding the delivery of new treatment options to patients by working to improve existing therapeutics through the application of highly specialized drug targeting platforms and formulation expertise. The Company focuses on underserved patient populations where it can have the greatest potential impact and currently has product candidates in clinical development designed to treat nephropathic cystinosis, non-alcoholic steatohepatitis ("NASH"), Huntington's Disease ("HD"), aldehyde dehydrogenase ("ALDH2") deficiency and a non-opioid solution designed for chronic pain.


News Articles [1309 Associated News Articles listed on BioPortfolio]

Critical Contrast: Raptor Pharmaceutical Corp

Bioverativ and Raptor Pharmaceutical Corp are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitabiliy, ri...

Head to Head Review: Raptor Pharmaceutical Corp

Raptor Pharmaceutical Corp and Prothena Corporation PLC are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, an...

Financial Analysis: Bioverativ

Bioverativ and Raptor Pharmaceutical Corp are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, ear...

Favorable Press Coverage Extremely Likely to Affect Raptor Pharmaceutical Corp (RPTP) Stock Price

Media stories about Raptor Pharmaceutical Corp have trended positive recently, Accern Sentiment reports. The research firm scores the sentiment of press coverage by analyzing more than 20 million blog...

Zomedica Pharmaceuticals Corp. Amends Quorum Requirement for Shareholder Meetings

ANN ARBOR, Mich., Sept. 21, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) ("Zomedica" or the "Company"), a veterinary pharmaceutical and health care solutions company, today...

Zomedica Pharmaceuticals Corp. Announces First Quarter 2017 Financial Results

ANN ARBOR, Mich., May 11, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) (“Zomedica” or “Company”), a veterinary pharmaceutical and health care solutions company, tod...

Raptor Pharmaceutical Corp (NASDAQ:RPTP) Earns Daily Coverage Optimism Score of 0.26

News headlines about Raptor Pharmaceutical Corp have trended positive recently, Accern Sentiment Analysis reports. Accern ranks the sentiment of media coverage by reviewing more than 20 million blog a...

Zomedica Pharmaceuticals Corp. to Present at SeeThruEquity and RHK Capital 2017 Disruptive Growth Company Showcase NYC

ANN ARBOR, Mich., Sept. 21, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a veterinary pharmaceutical and health care solutions company, today announced that it will presen...

PubMed Articles [180 Associated PubMed Articles listed on BioPortfolio]

Increased static and decreased capacity oxidation-reduction potentials in plasma are predictive of metabolic syndrome.

Electric conductivity in plasma is the balance between oxidized and reduced molecules (static Oxidation-Reduction Potential, sORP) and the amount of readily oxidizable molecules (capacity ORP, cORP). ...

mTOR/Raptor signaling is critical for skeletogenesis in mice through the regulation of Runx2 expression.

The mammalian target of rapamycin (mTOR)/regulatory-associated protein of mTOR (Raptor) pathway transmits and integrates different signals including growth factors, nutrients, and energy metabolism. N...

Bringing together raptor collections in Europe for contaminant research and monitoring in relation to chemicals regulations.

Raptors are good sentinels of environmental contamination and there is good capability for raptor biomonitoring in Europe. Raptor biomonitoring can benefit from natural history museums (NHMs), environ...

Raptor regulates functional maturation of murine beta cells.

Diabetes is associated with beta cell mass loss and islet dysfunctions. mTORC1 regulates beta cell survival, proliferation and function in physiological and pathological conditions, such as pregnancy ...

Variations in Oxidative Stress Levels in 3 Days Follow-up in Ultramarathon Mountain Race Athletes.

Spanidis, Y, Stagos, D, Orfanou, M, Goutzourelas, N, Bar-or, D, Spandidos, D, and Kouretas, D. Variations in oxidative stress levels in 3 days follow-up in ultramarathon mountain race athletes. J Stre...

Clinical Trials [207 Associated Clinical Trials listed on BioPortfolio]

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects Under Fasting Condition

- Objective: - To compare the rate and extent of absorption of Citalopram Hydrobromide Tablets 40 mg: Test Product: Citalopram Hydrobromide Tablets 40 mg manufactured b...

Bioequivalence Study of Hydrochlorothiazide 50mg Tablets Under Fasting Conditions

To compare the single-dose oral bioavailability of hydrochlorothiazide 50 mg tablet of Ohm Laboratories (A subsidiary of Ranbaxy pharmaceuticals USA) with hydrochlorothiazide 50 mg tablet ...

Companies [1318 Associated Companies listed on BioPortfolio]

Raptor Pharmaceutical

Raptor Pharmaceutical Inc. is the culmination of years of experience and research by a consortium of scientists, investors, and creative minds with one common goal, the development of novel protein th...

Raptor Pharmaceuticals Corp.

Raptor Pharmaceutical Corp. ("the Company") is dedicated to speeding the delivery of new treatment options to patients by working to improve existing therapeutics through the application of highly spe...

Raptor Pharmaceutical Corp.

NORLOFF COMPUTER CORP

Nil

ATLANTIS DRUG CORP

Nil

More Information about "Raptor Pharmaceuticals Corp." on BioPortfolio

We have published hundreds of Raptor Pharmaceuticals Corp. news stories on BioPortfolio along with dozens of Raptor Pharmaceuticals Corp. Clinical Trials and PubMed Articles about Raptor Pharmaceuticals Corp. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Raptor Pharmaceuticals Corp. Companies in our database. You can also find out about relevant Raptor Pharmaceuticals Corp. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record